Koers StemCells Inc Nasdaq
Aandelen
US85857R3030
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 13,97 mln. 12,98 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,32% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 02-08-88 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 01-01-22 |
Chief Tech/Sci/R&D Officer | - | 01/12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 28-11-16 |
Director/Board Member | 66 | 12-12-17 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 01-08-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,81% | 46,81 mld. | |
+46,73% | 41,29 mld. | |
-1,88% | 41,37 mld. | |
-6,20% | 28,87 mld. | |
+11,33% | 26,06 mld. | |
-21,00% | 19,13 mld. | |
-1,43% | 11,96 mld. | |
+30,73% | 12,39 mld. | |
-0,48% | 12,08 mld. |